Pure autonomic failure as an essential window into progression of synucleinopathies

1

Pure autonomic failure (PAF) is recognized as a prodromal state for synucleinopathies, including Parkinson's disease and multiple system atrophy.
2

The Queen Square study reported a 33% phenoconversion rate in PAF patients, aligning with previous studies on risk factors for neurodegenerative disorders.
3

Younger age at onset and severe genitourinary dysfunction are associated with phenoconversion to multiple system atrophy in PAF patients.
4

Dream enactment behavior is observed in 40% of PAF patients and may precede orthostatic intolerance, indicating potential synucleinopathy.
5

Diagnostic biomarkers like α-synuclein detection and imaging tools such as DaTScan are crucial for confirming PAF and assessing central involvement.

1